Jun 28, 2021 (Penny Stocks via COMTEX) -- 7 Penny Stocks to Watch With July Only a Week Away
As we turn the corner from June into July, there are plenty of penny stocks that investors are watching. This includes both popular and unpopular penny stocks to buy . But, with so many options on the table, how can investors decide which small-caps are the best? Well, there are a few ways to break this down.
First, investors can look to see what a company is doing in the short term and whether that aligns with any ongoing geopolitical or worldly events. This could be a good sign that a company is playing an active role in the market.
Additionally, investors can look to see what social media sentiment says about a company. This has become an extremely popular way to find penny stocks to watch and is only gaining more traction as time goes on. While this is not an extensive list, it should help to get you started on the right track. With that in mind, here are seven penny stocks to watch in July 2021.
7 Penny Stocks For Your July List
Iterum Therapeutics plc. ( NASDAQ: ITRM )
BEST Inc. ( NYSE: BEST )
Asensus Surgical Inc. ( NYSE: ASXC )
Iqstel Inc. ( OTC: IQST )
Senmiao Technology Ltd. ( NASDAQ: AIHS )
Cyren Ltd. ( NASDAQ: CYRN )
Rigel Pharmaceuticals Inc. ( NASDAQ: RIGL )
An interesting penny stock worth checking out is Iterum Therapeutics. As a clinical-stage pharmaceutical company, ITRM is focusing on the development of anti-infectives to combat multi-drug-resistant (MDR) pathogens. These pathogens present a large risk to many lives, as their resistance to drug treatments can be detrimental to potential therapies and preventative care. Working alongside the Centers for Disease Control (CDC), Iterum ensures it targets relevant organisms that are unmet by current therapies.
In the past few weeks, Iterum has seen a great deal of bullish sentiment from investors. Whether due to the emphasis on biotech from the pandemic or its own merit, the sentiment remains. Based in Dublin, Ireland, ITRM is run by experienced individuals such as its CEO, Corey Fishman, and CSO, Michael Dunne, M.D. Mr. Fishman had previously worked as the CEO at Durata Therapeutics. There he raised over $225 million in capital and oversaw all finance, administration, strategy, manufacturing, and business development operations.
While there are hundreds of biotech penny stocks to choose from, investors should take a close look at the company's leadership and what that means for it moving forward. With this in mind, will ITRM be on your penny stocks watchlist?
In the past couple of months, the technology market has seen tremendous investor interest as well as high levels of innovation. BEST Inc has been a part of this sector as a leader in the supply chain management sector. It uses proprietary technology to integrate smart supply chain systems with logistics solution providers.
Its comprehensive set of services include express and freight delivery, supply chain management, business-to-store-to-consumer supply chain, truckload capacity brokerage, international logistics, and financial services. With our world moving faster every day, the need for logistical services is always on the rise.
This is a one-stop-shop for many companies looking to optimize their supply chain models. BEST's goal is to empower businesses it works with, by leveraging innovative and advanced technology. In the end, it hopes to create a smarter, more efficient supply chain for its clients that is both cost and time-effective. With all of this in mind, is BEST stock worth adding to your watchlist?
Asensus Surgical is a penny stock that we've been covering extensively over the past few weeks. For some context as to what it does, it is directly involved in the digitization of interfaces between surgeons and patients. Building upon the back of Digital Laparoscopy, ASXC is using the Intelligent Surgical Unit to power the Senhance Surgical System. This is done to increase control during surgery and consequently reduce surgical variability. This machine offers improved visuals during operations as well as AI and deep learning capabilities.
This is a groundbreaking area of the medical field and one that ASXC is a pioneer in. On June 28th, Inselspital, University Hospital Bern, Switzerland announced that it has implemented the Senhance Surgical System program into its hospital. So far this will be the second of two other European hospitals that have begun to use the system so far in 2021.
Anthony Fernando, CEO of ASXC, commented. "We are very pleased they have started surgery with Senhance this week.'' While the sale of one surgical system is not necessarily a huge deal, the adoption of its technology is something that investors should consider. With this exciting news in mind, ASXC stock could be worth watching.
In late June, investors are witnessing a rise in attention on the technology sector. When looking for a tech penny stock to buy, investors should consider what technology it's working on, and how large the market size is for a given product. Today, IQST announced the appointment of three new members to its Board of Directors. Each of these new members holds extensive experience in the technology, financial and legal industries and are welcomed additions to the company.
Adding new members to a company's leadership is always intriguing for investors. It presents both an opportunity for a new direction and the potential to build on an existing business model. Considering this, will IQST be on your penny stocks watchlist?
Senmiao Technology is another penny stock that has been on our radar for quite some time now. With the current automobile shortage, AIHS is looking to establish itself as a leader in the industry. By specializing in automobile transactions and related services, AIHS provides an all-inclusive vehicle-related package. It does so by facilitating purchases, financing, operating leases, and guarantees between sellers and buyers. Recently AIHS announced a strategic deal with Didi, a top online ride-hailing platform in China.
This is a big deal and could cement AIHSs spot in the ride-hailing industry in China. While the results of this may not be fruitful until the details are fully fleshed out, in the meantime AIHS stock could be worth paying attention to.
Cyren Ltd. is a penny stock that many investors are watching right now. This innovative company is a producer of proprietary technologies that extend into areas such as machine learning and behavioral analytics. It also works in the field of high-level algorithms which it uses for big data-related projects. CYRN's goal is to use extensive detection techniques in order to block advanced cybersecurity threats promptly. With this, it can build strong internet security for the cloud-based era we live in.
In a world with constant advanced cyber threats, digital security companies are crucial to keeping the online ecosystem running and secure. The cloud is still a relatively novel technology that is now commonplace across all businesses and for individual use as well. During trading today, shares of CYRN stock shot up by a solid 6% or so at midday.
In its latest financial report posted last month, CYRN reported a slightly higher net loss alongside a slight decrease in revenue to $8.8 million for Q1 2021. This is not out of the blue as the pandemic has affected all aspects of business. But, with our world becoming more digital than ever, CYRN could see increased demand for its products moving forward.
The last penny stock on this list is Rigel Pharmaceuticals. This penny stock is a biotechnology company that operates in the healthcare industry. It focuses specifically on improving patient lives through the discovery, development, and novel drug solutions. Its drug offerings are in use primarily with patients suffering from hematologic disorders, cancers, and rare immune diseases.
Rigel has a strong pipeline of upcoming products as well as a portfolio of three staple commercial products. This allows it to operate broadly both as a commercial-stage drug developer and one with several products still in the pipeline. In the past month, shares of RIGL stock have shot up by a solid 22% and in the past year, that number jumps up to almost 150%. This includes sentiment from its compound fostamatinib which is in Phase 2 trials to treat hospitalized, Covid-19 patients.
And, during its most recent first quarter, the company reported more than $12.4 million in net product sales with a $125 million upfront cash payment from Eli Lilly for its RIP1 program. This is all exciting news and could continue to play out as Covid makes a small comeback. Considering this, will RIGL be on your list of penny stocks to watch?
Are You Investing in Penny Stocks Next Month?
Finding the best small-caps for your list of penny stocks to watch can be challenging. And with the world in a state of flux due to the pandemic, investing has never been more time-consuming.
However, with the power of the internet, any investor can become the most informed trader out there. And in 2021, having the most information on hand will separate you from the rest. Considering all of this, which penny stocks are you investing in next month?
Is there a problem with this press release? Contact the source provider Comtex at firstname.lastname@example.org. You can also contact MarketWatch Customer Service via our Customer Center.